Cause of death, by non-communicable diseases, ages 5-14, male in Chile
Chile: Cause of death, by non-communicable diseases, ages 5-14, male was 56.1% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Chile, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14, male in Chile stood at 56.1%.
That represents a change of down 9.0% on the previous year and up 11.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Chile peaked at 61.6% in 2020 and was at its lowest, 48.5%, in 2000.
Chile ranks 36th of 185 countries on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 5-14, male in Chile, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 48.5% | — |
| 2010 | 50.4% | +3.8% |
| 2015 | 54.3% | +7.8% |
| 2019 | 60.7% | +11.7% |
| 2020 | 61.6% | +1.6% |
| 2021 | 56.1% | -9.0% |
Chile compared with similar countries
- Chile's 56.1% is below the median for high income countries, which is 57.8%, 97% of the median. (58 countries reporting)
- Chile's 56.1% is above the median for Latin America & Caribbean, which is 40.6%, 1.4× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 48.5% | 48.5% | 48.5% | 1 |
| 2010s | 55.1% | 50.4% | 60.7% | 3 |
| 2020s | 58.8% | 56.1% | 61.6% | 2 |
Countries ranked near Chile
More health data for Chile
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4062 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,755 deaths per 1,000 people (2090)
- Number of infants who die before age 1 115 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0224 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Chile?
- Cause of death, by non-communicable diseases, ages 5-14, male in Chile was 56.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Chile?
- The highest recorded value was 61.6% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Chile?
- The lowest recorded value was 48.5% in 2000.
- How does Chile rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Chile ranks 36th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Chile?
- Over the last ten years it is up 11.3%. The long-run trend across the full record is rising.
- Where does this Chile data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.